Patch Testing to Exclude Allergic Contact Dermatitis Caused by Povidone-Iodine

Dermatology ◽  
2002 ◽  
Vol 204 (1) ◽  
pp. 96-98 ◽  
Author(s):  
Takehito Kozuka
Keyword(s):  
Contact Dermatitis ◽  
Allergic Contact Dermatitis ◽  
Patch Testing ◽  
Povidone Iodine ◽  
Allergic Contact

Systemic Pustular Allergic Contact Dermatitis induced by thioureas: report of a case with recurrence upon patch testing

2021 ◽  
Author(s):  
Laurence Lemieux ◽  
Louis‐Philippe Gagnon ◽  
Jean Bernard ◽  
Marie‐Claude Houle
Keyword(s):  
Contact Dermatitis ◽  
Allergic Contact Dermatitis ◽  
Patch Testing ◽  
Allergic Contact

Changes in Product Use and Quality of Life After Patch Testing in Children With Allergic Contact Dermatitis

Dermatitis ◽  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Bruin Pollard ◽  
Reid W. Collis ◽  
Dylan Stahl ◽  
Carrie C. Coughlin ◽  
David M. Sheinbein
Keyword(s):  
Quality Of Life ◽  
Contact Dermatitis ◽  
Allergic Contact Dermatitis ◽  
Patch Testing ◽  
Product Use ◽  
Allergic Contact

Patch testing and diagnosis when suspecting allergic contact dermatitis from medical devices

2020 ◽  
Vol 83 (4) ◽  
pp. 333-335
Author(s):  
Josefin Ulriksdotter ◽  
Martin Mowitz ◽  
Cecilia Svedman ◽  
Magnus Bruze
Keyword(s):  
Contact Dermatitis ◽  
Allergic Contact Dermatitis ◽  
Medical Devices ◽  
Patch Testing ◽  
Allergic Contact

scholarly journals An Adverse Reaction in the Pediatric Sleep Laboratory

2016 ◽  
Vol 2016 ◽  
pp. 1-2 ◽  
Author(s):  
Diana Reppucci ◽  
Debra Medin ◽  
Suhail Al-Saleh ◽  
Mary Jane Smith ◽  
Jill Barter ◽  
...  
Keyword(s):  
Adverse Reaction ◽  
Contact Dermatitis ◽  
Allergic Contact Dermatitis ◽  
Povidone Iodine ◽  
Central Sleep Apnea ◽  
Positive Pressure ◽  
Apnea Hypopnea Index ◽  
Iodine Solution ◽  
Allergic Contact ◽  
Povidone Iodine Solution

We present a case of a 15-month-old boy with Cornelia de Lange Syndrome (NIPBL gene mutation). On a PSG, central sleep apnea (central apnea-hypopnea index of 19/hour) and nocturnal hypoventilation (transcutaneous CO2> 50 mmHg for 53% of the night) were found. A positive pressure initiation study was aborted because the patient developed a serious adverse reaction. The differential diagnosis included a skin fragility condition versus an allergic contact dermatitis to the interface; this could be from the povidone-iodine solution used to clean the NiPPV interface or from the plastic of the interface itself. A skin biopsy was performed which was normal. The reaction was likely secondary to an allergic contact dermatitis from the povidone-iodine solution used to clean the NiPPV interface. The patient is currently tolerating NiPPV.

Usefulness of Patch Testing With Patient's Own Products in the Diagnosis of Allergic Contact Dermatitis

Dermatitis ◽  
2021 ◽  
Vol 32 (1) ◽  
pp. 38-41
Author(s):  
Fátima Tous-Romero ◽  
Pablo L. Ortiz Romero ◽  
Javier Ortiz de Frutos
Keyword(s):  
Contact Dermatitis ◽  
Allergic Contact Dermatitis ◽  
Patch Testing ◽  
Allergic Contact

Patch testing procedures in patients suffering from suspected allergic contact dermatitis to minoxidil

1989 ◽  
pp. 267-271
Author(s):  
J. M. Lachapelle ◽  
D. Tennstedt ◽  
B. Leroy ◽  
V. Van den Haute ◽  
F. Naert
Keyword(s):  
Contact Dermatitis ◽  
Allergic Contact Dermatitis ◽  
Patch Testing ◽  
Testing Procedures ◽  
Allergic Contact

Allergic Contact Dermatitis from Exotic Woods: Importance of Patch-Testing with Patient-Provided Samples

Dermatitis ◽  
2011 ◽  
Vol 22 (2) ◽  
pp. E1-E6 ◽  
Author(s):  
Joshua O. Podjasek ◽  
Robert H. Cook-Norris ◽  
Donna M. Richardson ◽  
Lisa A. Drage ◽  
Mark D.P. Davis
Keyword(s):  
Contact Dermatitis ◽  
Allergic Contact Dermatitis ◽  
Patch Testing ◽  
Allergic Contact

Patch Testing in Vulvar Allergic Contact Dermatitis

Dermatitis ◽  
2018 ◽  
Vol 29 (2) ◽  
pp. 95-96 ◽  
Author(s):  
Megha K. Trivedi ◽  
Carina M. Woodruff ◽  
Rachel Kornik ◽  
Nina Botto
Keyword(s):  
Contact Dermatitis ◽  
Allergic Contact Dermatitis ◽  
Patch Testing ◽  
Allergic Contact

Allergic Contact Dermatitis Secondary to Moisturizers

2020 ◽  
Vol 24 (4) ◽  
pp. 350-359
Author(s):  
Stephanie R. Cohen ◽  
Jesús A. Cárdenas-de la Garza ◽  
Paige Dekker ◽  
Wasim Haidari ◽  
Sarah S. Chisolm ◽  
...  
Keyword(s):  
Contact Dermatitis ◽  
Allergic Contact Dermatitis ◽  
Patch Testing ◽  
Adverse Reactions ◽  
Healthcare Providers ◽  
Standard Series ◽  
The North ◽  
Allergenic Potential ◽  
Skin Conditions ◽  
Allergic Contact

Background: Moisturizers are cosmetic products used routinely to manage various skin conditions. Even though moisturizers are often thought to have minimal or no adverse reactions, allergic contact dermatitis (ACD) to these products can develop in some cases. Methods: We studied ingredients included in 3 of the most commonly used moisturizer brands, identified their presence in standard patch testing series, and evaluated their allergenic potential, categorizing the allergens as frequent or infrequent. The standard patch testing series used as reference were the Thin-layer Rapid Use Epicutaneous patch test (T.R.U.E. test), the North American Contact Dermatitis Group (NACDG) screening standard series, and the American Contact Dermatitis Society (ACDS) core allergen series. Results: Aveeno, Cetaphil, and Cerave products had a total of 12, 14, and 9 potential allergens, respectively, the majority of which were infrequent and not included in standard patch testing series. Conclusion: Being aware of the allergenic potential of commonly used moisturizers may help healthcare providers when evaluating patients with ACD. Further testing is recommended in a targeted manner when suspecting ACD with negative standard patch testing series or when ACD is refractory to treatment.

Sign in / Sign up

Export Citation Format

Share Document